Ali Arif Nasir → Entero Therapeutics, Inc. GRDX

Stake: 4.90% Shares: 230,900 CUSIP: 33749P408 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

31,133 shares short · -25.3% vs prior

Post-Filing Returns · since 2025-06-06 on GRDX

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 4.35 on closest trading day on/after 2025-06-06. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Entero Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-08	SCHEDULE 13D	Sawyer Jason David	7.10%	540,000	view →
2021-02-10	SC	Ross Edmund Burke Jr.	—	—	view →
2020-08-11	SC	Ross Edmund Burke Jr.	—	—	view →
2020-01-29	SC	Ross Edmund Burke Jr.	—	—	view →
2019-01-08	SC	Ross Edmund Burke Jr.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →